Standardized added metabolic activity (SAM) IN 18F-FDG PET assessment of treatment response in colorectal liver metastases
2013) EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 40(8). p.1214-1222 Mark(
- Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases
Preoperative chemotherapy for colorectal liver metastases: prediction of response by DCE-MRI abd FDG-PET/CT?
2011) EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 38(suppl. 2). p.S195-S195 Mark(
- PET as a predictor of metabolic response to antiangiogenic therapy in metastatic colorectal cancer (mCRC)
- An evaluation of FDG-PET as a predictor of metabolic response to chemotherapy in metastatic colorectal cancer patients (mCRC)